Skip to main content
. 2022 Apr 18;22(7):990–1001. doi: 10.1016/S1473-3099(22)00144-X

Figure 1.

Figure 1

Study flow chart for participants with evidence of previous exposure to SARS-CoV-2 at baseline who were included in the secondary analyses

*Other reasons included administrative reasons, contraception requirements being unacceptable, personal medical reasons, withdrawal by volunteers before receiving dose one, etc. †Includes only participants who had received their second dose at the time of data cutoff.